Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lenvima® (lenvatinib) – New indication
August 15, 2018 - The FDA announced the approval of Lenvima (lenvatinib), for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).
